Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lanoiselée, Julien
PALAO, NCT04140331: Level of Accelerometer-assessed Preoperative Physical Activity and Short Term Outcome After Elective Cardiac Surgery	Terminated	N/A	202	Europe	Accelerometer	Centre Hospitalier Universitaire de Saint Etienne	Heart Diseases	04/24	06/24
LANOISELEE, Julien
PRADO, NCT03822793: A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty	Recruiting	2	170	Europe	Placebo, Group 1: perfusion of 300 mg Exacyl, Group 2: perfusion of 500 mg Exacyl, Group 3: perfusion of 1000 mg Exacyl, Group 4: perfusion of 3000 mg Exacyl	Centre Hospitalier Universitaire de Saint Etienne	Arthropathy of Hip	12/26	12/26
ProApix, NCT06474182: Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma	Not yet recruiting	N/A	32	Europe	Blood sampling, Apixaban	Centre Hospitalier Universitaire de Saint Etienne	Multiple Myeloma, Total Knee Replacement	03/27	09/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lanoiselée, Julien
PALAO, NCT04140331: Level of Accelerometer-assessed Preoperative Physical Activity and Short Term Outcome After Elective Cardiac Surgery	Terminated	N/A	202	Europe	Accelerometer	Centre Hospitalier Universitaire de Saint Etienne	Heart Diseases	04/24	06/24
LANOISELEE, Julien
PRADO, NCT03822793: A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty	Recruiting	2	170	Europe	Placebo, Group 1: perfusion of 300 mg Exacyl, Group 2: perfusion of 500 mg Exacyl, Group 3: perfusion of 1000 mg Exacyl, Group 4: perfusion of 3000 mg Exacyl	Centre Hospitalier Universitaire de Saint Etienne	Arthropathy of Hip	12/26	12/26
ProApix, NCT06474182: Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma	Not yet recruiting	N/A	32	Europe	Blood sampling, Apixaban	Centre Hospitalier Universitaire de Saint Etienne	Multiple Myeloma, Total Knee Replacement	03/27	09/27